Pulmonary and Respiratory Medicine

A topic in the Science corpus, drawn from 6,159 papers.

Trusted voices in Pulmonary and Respiratory Medicine

Ordered by the trust Pulmonary and Respiratory Medicine's own network concentrates on each researcher, most first.

  1. Christian Schoof — trusted by 37 researchers here
  2. Brent R. Stockwell — trusted by 64 researchers here
  3. Juan Pablo Bello — trusted by 46 researchers here
  4. Justin Salamon — trusted by 46 researchers here
  5. Paul S. Addison — trusted by 32 researchers here
  6. Richard B. Reilly — trusted by 22 researchers here
  7. Philip de Chazal — trusted by 22 researchers here
  8. Kunio Doi — trusted by 31 researchers here
  9. Ralph Weissleder — trusted by 20 researchers here
  10. TA Wynn — trusted by 28 researchers here
  11. Jean-Claude Klein — trusted by 35 researchers here
  12. Scott J. Dixon — trusted by 22 researchers here

Most-cited papers in Pulmonary and Respiratory Medicine

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). (2009, European Journal of Cancer) — 26,513 citations
  2. Geant4—a simulation toolkit (2003) — 18,198 citations
  3. Ferroptosis: an iron-dependent form of nonapoptotic cell death. (2012, Cell) — 15,723 citations
  4. Standardisation of spirometry (2005, European Respiratory Journal) — 15,210 citations
  5. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary (2016, Acta Neuropathologica) — 14,109 citations
  6. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, American Journal of Respiratory and Critical Care Medicine) — 13,352 citations
  7. New guidelines to evaluate the response to treatment in solid tumors (2000, Journal of the National Cancer Institute) — 12,595 citations
  8. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. (2000, New England Journal of Medicine) — 11,783 citations
  9. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. (2002, The Lancet) — 9,928 citations
  10. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (2004, Science) — 9,841 citations
  11. Neutrophil Extracellular Traps Kill Bacteria (2004, Science) — 9,686 citations
  12. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021, Neuro-Oncology) — 9,662 citations
  13. Epithelial-mesenchymal transitions in development and disease. (2009, Cell) — 9,583 citations
  14. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. (2016, New England Journal of Medicine) — 8,730 citations
  15. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. (2002, Journal of the American Medical Association (JAMA)) — 8,611 citations
  16. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (2020, New England Journal of Medicine) — 8,431 citations
  17. Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer (2015, New England Journal of Medicine) — 8,405 citations
  18. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study (2020, The Lancet Respiratory Medicine) — 8,377 citations
  19. The Cancer Genome Atlas Pan-Cancer Analysis Project (2013) — 8,331 citations
  20. Cystic Fibrosis (2009, Journal of the Iowa Medical Society) — 8,078 citations
  21. Inferring tumour purity and stromal and immune cell admixture from expression data (2013, Nature Communications) — 7,904 citations
  22. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer (2015, New England Journal of Medicine) — 7,839 citations
  23. Acute Respiratory Distress Syndrome (2016) — 7,807 citations
  24. Epidemiology and causes of preterm birth (2008, The Lancet) — 7,400 citations
  25. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing (2012, New England Journal of Medicine) — 7,381 citations
  26. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. (2009, The Lancet Oncology) — 7,309 citations
  27. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, Journal of Vascular Surgery) — 6,901 citations
  28. Geant4 developments and applications (2006, IEEE Transactions on Nuclear Science) — 6,891 citations
  29. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised… (2010, The Lancet) — 6,747 citations
  30. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. (2017, Cell) — 6,633 citations
  31. Regulation of Ferroptotic Cancer Cell Death by GPX4 (2014, Cell) — 6,626 citations
  32. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer (2015, Science) — 6,586 citations
  33. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging (2017, Ca) — 6,578 citations
  34. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. (2016, The Lancet) — 6,522 citations
  35. Ferroptosis: mechanisms, biology and role in disease (2021, Nature reviews. Molecular cell biology) — 6,478 citations
  36. MGMT gene silencing and benefit from temozolomide in glioblastoma. (2005, New England Journal of Medicine) — 6,463 citations
  37. A randomized trial of intraarterial treatment for acute ischemic stroke. (2015, New England Journal of Medicine) — 6,022 citations
  38. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. (2006, New England Journal of Medicine) — 6,007 citations
  39. Transcatheter versus surgical aortic-valve replacement in high-risk patients. (2011, New England Journal of Medicine) — 5,975 citations
  40. Expert consensus document on arterial stiffness: methodological issues and clinical applications. (2006, European Heart Journal) — 5,946 citations
  41. Interpretative strategies for lung function tests (2005, European Respiratory Journal) — 5,888 citations
  42. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (2001, New England Journal of Medicine) — 5,870 citations
  43. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. (2006, New England Journal of Medicine) — 5,863 citations
  44. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. (2016, The Lancet) — 5,819 citations
  45. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (2004, New England Journal of Medicine) — 5,761 citations
  46. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. (2008, Arthritis & Rheumatism) — 5,742 citations
  47. The incidence of congenital heart disease. (2002, Journal of the American College of Cardiology) — 5,722 citations
  48. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. (2001, American Journal of Respiratory and Critical Care Medicine) — 5,719 citations
  49. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. (2013, Arthritis & Rheumatism) — 5,587 citations
  50. Global status report on road safety (2009, Injury Prevention) — 5,574 citations

Most active researchers

By papers in this topic: a volume measure, not trust.